Excellergy is a Biotech company based in Palo Alto, California. It has raised $70M in total funding. Latest round: Series A.
Excellergy funding overview
Excellergy is a Biotech company based in Palo Alto, California. Excellergy has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Excellergy runs through 2025; nothing later has been disclosed. Investors on record include Samsara BioCapital, Red Tree Venture Capital, Decheng Capital. 3 distinct backers are named across the disclosed rounds.
Excellergy at a glance
Total raised
$70M
Latest round
Series A
Latest round date
October 2025
Industry
Biotech
Headquarters
Palo Alto, California
Notable investors
Samsara BioCapital, Red Tree Venture Capital, Decheng Capital
Frequently asked about Excellergy funding
How much has Excellergy raised?
Excellergy has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Excellergy?
Samsara BioCapital, Red Tree Venture Capital, Decheng Capital are named among the investors backing Excellergy.
What was the latest Excellergy funding round?
The most recent disclosed round is a Series A, announced in October 2025.
Where is Excellergy based?
Excellergy is based in Palo Alto, California.
What sector does Excellergy operate in?
Excellergy is tracked under Biotech from Palo Alto, California, with $70M in disclosed funding.
When did Excellergy last raise?
The last disclosed Excellergy round closed in October 2025 at Series A.
Every Excellergy figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Palo Alto at a similar stage.
